<DOC>
	<DOCNO>NCT00856349</DOCNO>
	<brief_summary>The purpose clinical trial determine whether periodic therapy programming report illustrate physician usage shock reduction program increase utilization recommend program guideline defibrillator .</brief_summary>
	<brief_title>Medtronic Shock-Less Study Physician Utilization Shock Reduction Programming</brief_title>
	<detailed_description>Shocks deliver patient defibrillator , life-saving , create anxiety , pain decrease quality life . Previous study show device program feature safely reduce number shock patient receive . This study explore extent physician use program feature . It determine whether repeat frequent awareness program subject program trend enrolled subject change program pattern . This accomplish understanding physician ' device programming behavior provide report tool help physician manage subject provide shock reduction program recommend previous publication .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Subject ( subject 's legally authorize representative ) willing able sign date Patient Consent Form ( PCF ) authorization access use health information , applicable Subject implant Medtronic market release ICD CRTD device ( US/Canada Concerto®/Virtuoso® new model ; AsiaPacific , Israel , Latin America EnTrust™ , InSync Sentry® , Concerto®/Virtuoso® new model ) within past 30 day Subject commercially release RA ( applicable ) , RV , LV ( applicable ) lead Subject enrol concurrent study approve concurrent enrollment Medtronic Clinical Trial Leader</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Implantable Cardioverter Defibrillator ( ICD )</keyword>
	<keyword>Cardiac Resynchronization Therapy-Defibrillator ( CRT-D )</keyword>
	<keyword>Lead Integrity Alert ( LIA )</keyword>
	<keyword>Therapy Programming Report ( TPR )</keyword>
</DOC>